1 unknown, 1 withdrawn. 1 Early Phase 1, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Unknown 1 |
| Phase 1 | 1 | Withdrawn 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow [18F]-FDG: new trials by email Literature Review of [18F]-FDG trials Research Report on [18F]-FDG
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Monitoring Early Response to Targeted Therapy in Stage IV HER2+ Breast Cancer Patients With Advanced PET/MR Imaging [18F]-FDG - HER2-positive Breast Cancer | Phase 1 / Phase 2 | Withdrawn | University of Alabama at Birmingham | 2026-03-01 | 2026-07-01 | |
| Positron Emission Tomograph(PET) Imaging Explores the Role of SF-DEVD-2 in Monitoring Tumor Efficacy [18F]SF-DEVD-2, [18F]-FDG - Breast Cancer Stage II, Breast Cancer Stage III | Early Phase 1 | Unknown | Affiliated Hospital of Jiangnan University | 10 | 2023-01-01 | 2023-04-25 |
Breast Neoplasms (1)
Affiliated Hospital of Jiangnan University (1) · University of Alabama at Birmingham (1)
China (1) · United States (1)
Anna Sorace, PhD (1) · Chunjing Yu (1)